GHX gains high-profile member

Article

Siemens Medical Solutions has joined Global Healthcare Exchange (GHX) as a principal equity member. GHX is an Internet-based trading exchange intent on building an industry-standard catalog from which hospitals can purchase both medical and nonmedical

Siemens Medical Solutions has joined Global Healthcare Exchange (GHX) as a principal equity member. GHX is an Internet-based trading exchange intent on building an industry-standard catalog from which hospitals can purchase both medical and nonmedical products. Equity members include GE Medical Systems, Johnson & Johnson, Medtronic, and Tyco International. Joining GHX complements Siemens’ e-business strategy, which is directed at providing the healthcare community with online training and consulting, ASP solutions, new ways to purchase equipment and supplies, remote equipment management, and health management tools.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.